Cardiac Protective Effect of Kirenol against Doxorubicin-Induced Cardiac Hypertrophy in H9c2 Cells through Nrf2 Signaling via PI3K/AKT Pathways
Kirenol (KRL) is a biologically active substance extracted from Herba Siegesbeckiae. This natural type of diterpenoid has been widely adopted for its important anti-inflammatory and anti-rheumatic properties. Despite several studies claiming the benefits of KRL, its cardiac effects have not yet been...
Main Authors: | Abdullah M. Alzahrani, Peramaiyan Rajendran, Vishnu Priya Veeraraghavan, Hamza Hanieh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/6/3269 |
Similar Items
-
Mangiferin Inhibits Apoptosis in Doxorubicin-Induced Vascular Endothelial Cells via the Nrf2 Signaling Pathway
by: Mohammad Bani Ismail, et al.
Published: (2021-04-01) -
Protective effect of limonin against doxorubicin-induced cardiotoxicity via activating Nuclear factor - like 2 and Sirtuin 2 signaling pathways
by: Jie Deng, et al.
Published: (2021-09-01) -
Protective Effects of Kirenol against Lipopolysaccharide-Induced Acute Lung Injury through the Modulation of the Proinflammatory NFκB Pathway and the AMPK2-/Nrf2-Mediated HO-1/AOE Pathway
by: Frank Cheau-Feng Lin, et al.
Published: (2021-01-01) -
Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK/NF-kB signaling pathways
by: El-Agamy DS, et al.
Published: (2018-12-01) -
Attenuation of doxorubicin-induced cardiotoxicity in a human in vitro cardiac model by the induction of the NRF-2 pathway
by: Lauren Tomlinson, et al.
Published: (2019-04-01)